X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/dova-announces-doptelet-avatrombopag-data-presentations-at-upcoming-62nd-american-society-of-hematology-annual-meeting-and-exposition-301179444.html
https://www.prnewswire.com/news-releases/dova-granted-orphan-drug-designation-for-avatrombopag-for-the-treatment-of-chemotherapy-induced-thrombocytopenia-300985361.html
https://www.prnewswire.com/news-releases/additional-analyses-from-phase-3-study-with-doptelet--avatrombopag-for-the-treatment-of-chronic-immune-thrombocytopenia-provides-evidence-of-long-term-response-rates-300971110.html
https://www.biospace.com/article/releases/sobi-successfully-completes-acquisition-of-dova-pharmaceuticals/?s=79
https://www.biopharmadive.com/news/sobi-acquires-dova-doptelet-rare-disease-hematology/564004/
https://www.fiercepharma.com/marketing/dova-takes-novartis-blockbuster-2nd-doptelet-fda-nod-slashes-price?utm_source=internal&utm_medium=rss
https://www.fiercepharma.com/marketing/cosmo-to-give-bausch-health-sales-a-run-latest-fda-nod-for-xifaxan-rival
Market Place
Share 
